Concepedia

Author

Yutian Wei

Jiangsu Province HospitalORCID

Also Known As

Kevin Zhu, Wei Yutian, Y. Wei, Yutian Wei

34

Publications

1.3K

Citations

14

H-Index

36

Concepts

All Affiliations

Jiangsu Province HospitalNanjing Medical UniversityJiangsu Cancer HospitalSecond Military Medical UniversityChanghai Hospital
YW

About

Yutian Wei is an author at Jiangsu Province Hospital specializing in medicine, radiation oncology, and cellular therapies.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

47

2

Health Sciences

1

1

11

3

Biology

1

1

11

4

Cell Biology

1

1

15

5

Cellular Therapies

1

1

21

Yutian Wei

×

13

Publications

1.2K

Citations

12

H-Index

YearCitations

DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma

Chenfei Lu, Yutian Wei, Xiefeng Wang,

Molecular Cancer

2020

341

EIF4A3-induced circular RNA ASAP1 promotes tumorigenesis and temozolomide resistance of glioblastoma via NRAS/MEK1/ERK1–2 signaling

Yutian Wei, Chenfei Lu, Peng Zhou,

Neuro-Oncology

2020

294

Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma

Zhuoran Zhang, Jianxing Yin, Chenfei Lu,

Journal of Experimental & Clinical Cancer Research

2019

263

Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p

Jianxing Yin, Xin Ge, Zhumei Shi,

Theranostics

2020

108

Fetuin-A alleviates neuroinflammation against traumatic brain injury-induced microglial necroptosis by regulating Nrf-2/HO-1 pathway

Pengzhan Zhao, Yutian Wei, Guangchi Sun,

Journal of Neuroinflammation

2022

70

MiR-181b suppress glioblastoma multiforme growth through inhibition of SP1-mediated glucose metabolism

Jianxing Yin, Zhumei Shi, Wenjin Wei,

Cancer Cell International

2020

37

Meningioma achieves malignancy and erastin-induced ferroptosis resistance through FOXM1-AURKA-NRF2 axis

Yangfan Ye, Lei Xu, Liuchao Zhang,

Redox Biology

2024

23

Safety and efficacy of a novel anti-CD20 chimeric antigen receptor (CAR)-T cell therapy in relapsed/refractory (r/r) B-cell non-Hodgkin lymphoma (B-NHL) patients after failing CD19 CAR-T therapy.

Aibin Liang, Shiguang Ye, Ping Li,

Journal of Clinical Oncology

2021

21

SP1-upregulated LBX2-AS1 promotes the progression of glioma by targeting the miR-491-5p/LIF axis

Wentao Li, Ismatullah Soufiany, Xiao Lyu,

Journal of Cancer

2021

18

Identification and verification of hub genes associated with the progression of non-small cell lung cancer by integrated analysis

Mengyan Xie, Kun Ding, Xinming Jing,

Frontiers in Pharmacology

2022

15

Page 1